Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1996
11/27/1996EP0743851A1 Lipophilic carrier preparations
11/27/1996EP0743850A1 Rapidly dissolving oral dosage form
11/27/1996EP0662835B1 New pharmaceutical formulations of spiramycine
11/27/1996EP0625900B1 Compositions and processes for the sustained release of drugs
11/27/1996EP0568651A4 Biodegradable polymer blends for drug delivery
11/27/1996EP0495878B1 Method for purifying chelator conjugated compounds
11/27/1996CN1136776A Oral formulations of antifungal
11/27/1996CN1136773A Transdermal delivery device
11/27/1996CN1136555A Nerve amide compound, its preparing method and its use
11/27/1996CN1136436A Tablet for clearing head for cerebrorascular disease
11/26/1996US5578719 Sulphonated derivatives of cyclomalto-oligosaccharides, their preparation process and support for active substances containing these derivatives
11/26/1996US5578709 Polyvinylpyrrolidone, polyoxyethylene glycol
11/26/1996US5578706 Methods and compositions concerning homogenous immunotoxin preparations
11/26/1996US5578704 Bone disorders
11/26/1996US5578644 Periodically applying isocitric acid or salt to face
11/26/1996US5578600 Vitamins b1 and b12, sugar alcohol
11/26/1996US5578585 Pleuromutilin derivative complexes
11/26/1996US5578567 Nasal pharmaceutical composition
11/26/1996US5578496 Detection of autoantibodies associated with the disease myasthenia gravis
11/26/1996US5578325 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
11/26/1996US5578324 Peptide proteinaceous drug nasal powder composition
11/26/1996US5578323 Proteinoid carriers and methods for preparation and use thereof
11/26/1996US5578320 Method of dehydrating liposomes using protective sugars
11/26/1996US5578316 Palatable pharmaceutical compositions
11/26/1996US5578305 Methods and preparations for preventing adhesions to organs and parts of organs
11/26/1996US5578289 Administering antibody-enzyme conjugate
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/26/1996CA2069906C Uncharged morpholino-based polymers having achiral intersubunit linkages
11/26/1996CA2027592C Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
11/26/1996CA1338736C Microcrystals containing an active ingredient with affinity for phospholipids and at least one phospholipid; process for preparing the same
11/21/1996WO1996036367A1 Composition and method for tumor imaging
11/21/1996WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996WO1996036360A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies
11/21/1996WO1996036357A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996WO1996036356A1 Viral agent associated with mystery swine disease
11/21/1996WO1996036352A1 Liquid formulations for proteinic pharmaceuticals comprising at least 2 absorption enhancers
11/21/1996WO1996036340A1 STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION
11/21/1996WO1996036338A1 Bisacodyl dosage form for colonic delivery
11/21/1996WO1996036329A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
11/21/1996WO1996036323A1 Cosmetic make-up compositions
11/21/1996WO1996036322A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
11/21/1996WO1996036321A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
11/21/1996WO1996036319A1 Pharmaceutical dosage form for colonic delivery
11/21/1996WO1996036318A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
11/21/1996WO1996036317A1 Production scale method of forming microparticles
11/21/1996WO1996036316A1 Self-emulsifying formulations of lipophilic drugs
11/21/1996WO1996036315A1 Sterilisable paste product for topical application
11/21/1996CA2227326A1 Carbohydrate-mediated coupling of peptides to immunoglobulins
11/21/1996CA2221464A1 Cosmetic make-up compositions
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2221145A1 Self-emulsifying formulations of lipophilic drugs
11/21/1996CA2220451A1 Methods and compositions for improving digestion and absorption in the small intestine
11/21/1996CA2218898A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd19 antibodies
11/21/1996CA2217852A1 Sterilisable paste product for topical application
11/20/1996EP0743059A2 Process for applying antibacterial oral composition to dental implant areas
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742818A1 Macroencapsulated secretory cells
11/20/1996EP0742722A1 Method for increasing bioavailability of oral pharmaceutical compositions
11/20/1996EP0742715A1 Oral liquid compositions containing paroxetine resinate
11/20/1996EP0742714A1 Liquid pharmaceutical compositions comprising thyroid hormones
11/20/1996EP0648108B1 Prophylactic and therapeutical preparation against caries
11/20/1996EP0550544B1 Antigen-antibody conjugates
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136274A Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
11/19/1996US5576346 Administering a substituted chromone
11/19/1996US5576329 Method for treating tendon or joint inflammation with papaverine HCL
11/19/1996US5576311 Cyclodextrins as suspending agents for pharmaceutical suspensions
11/19/1996US5576305 Intercellular adhesion mediators
11/19/1996US5576288 Fibroblast growth factor conjugates
11/19/1996US5576220 Thin film HPMP matrix systems and methods for constructing and displaying ligands
11/19/1996US5576025 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
11/19/1996US5576024 Buffered matrix aspirin
11/19/1996US5576016 Solid fat nanoemulsions as drug delivery vehicles
11/19/1996US5576012 Pharmaceutical aqueous formulations containing a sparingly soluble pharmaceutical active compound with a solubilizing polymeric agent
11/19/1996US5575993 Useful as herbicides, microbiocides, plant growth regulators, pharmaceuticals, disinfectants, algicides, sanitizers, and preservatives
11/19/1996US5575987 Method of producing sustained-release microcapsules
11/19/1996US5575652 Process for applying antibacterial oral composition to dental implant areas
11/14/1996WO1996035721A1 A dicarboxylic acid hemiester or hemiamide with a pharmacologically active compound and with hyaluronic acid or with a hyaluronic acid ester, a process for its preparation and a controlled release medicament containing this derivative
11/14/1996WO1996035720A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
11/14/1996WO1996035451A1 Novel toxin complex
11/14/1996WO1996035434A1 Laryngeal bactericidal and antiseptic composition
11/14/1996WO1996035427A1 Transdermal therapeutic system for administering testosterone
11/14/1996WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage
11/14/1996WO1996032134A3 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/14/1996DE19614847A1 Phyto-chemical pharmaceutical compsn.
11/14/1996CA2220358A1 Transdermal therapeutic system (tts) for the administration of testosterone
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/13/1996EP0742015A1 Prodrugs for beta-lactamase and uses thereof
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0742013A1 Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
11/13/1996EP0742011A1 Percutaneously absorbable preparation
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741734A1 Phenylboronic acid complexes
11/13/1996EP0741687A1 Leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741574A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
11/13/1996EP0741572A1 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14$g(a),17$g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17$g(b)-DIOL
1 ... 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 ... 1712